Introduction
Cellular responses to g-irradiation include growtharrest and death. Growth-arrest, which is known to occur in G1 or G2, allows for the detection and repair of damaged DNA and serves to prevent the passage of mutations to progeny cells. Aberrant cells, in which DNA is either unrepaired or misrepaired following irradiation, may carry mutations predisposing to malignancy and it is thought that such cells are normally deleted. Death of g-irradiated cells may occur either rapidly from G1 (interphase death) or after a delay following G2 arrest (mitotic death) and, in each case, involves activation of the innate cell-death programme, apoptosis (Kruman et al., 1991; Radford, 1994) . G1 arrest and interphase death can be driven by wild type p53, expression of which increases after irradiation (Kastan et al., 1991; O'Connor et al., 1993; Michalovitz et al., 1990; Yonish-Rouach et al., 1991) , whereas G2 arrest and post-mitotic death are mainly p53-independent responses (Bracey et al., 1995; Kastan et al., 1992; Strasser et al., 1994) .
Cell survival following g-irradiation is enhanced by factors which, directly or indirectly, inhibit the apoptotic process. Exogenous growth/survival factors, such as IFN-g, IL-2, IL-3, IL-4 and IL-7 suppress DNA-damage-induced apoptosis (Canman et al., 1995; Collins et al., 1992; Sangfelt et al., 1996; Seki et al., 1995) . Constitutive expression of bcl-2, the prototype survival gene, also promotes survival of cells exposed to radiation and other DNAdamaging agents (Collins et al., 1992; Gilbert et al., 1996; Kyprianou et al., 1997; Lock and Stribinskiene, 1996; Sentman et al., 1991; Strasser et al., 1994; Soldatenkov et al., 1996) .
Studies of prognostic indicators of tumour responses to treatment, including radiotherapy, have shown that, whilst expression of Bcl-2 can indicate a poor prognosis (as would be expected as a result of its capacity to prevent apoptosis), in other similarly classi®ed tumours prognosis is actually improved by the presence of Bcl-2 (Pezzella et al., 1992; Piris et al., 1994; Tjalma et al., 1997) . Prevention of apoptosis by Bcl-2 following DNA damage does not therefore guarantee enhanced longterm survival of tumour cells. In the present study we have used a Burkitt Lymphoma (BL) cell model to investigate the basis of the heterogeneity in tumour cell responses to irradiation in the presence of Bcl-2. The results indicate that Bcl-2 is highly eective in preventing apoptosis, as assessed in short-term assays, but can also eventually activate apoptosis through its ability to promote growth arrest. L3055 and MUTU. These lines, which are Bcl-2-negative ( Figure 1 ) were compared with their Bcl-2-expressing counterparts (CHEP/Bcl-2, L3055/Bcl-2 and MUTU/Bcl-2) obtained by stable transfection with bcl-2 (Figure 1) . Figure 2 (a ± c) shows the radiation-induced apoptotic responses of these lines over a 7-day period. The three parental lines exhibited varying patterns of radiation-induced apoptosis: CHEP BL cells died rapidly with the majority of apoptosis occurring within the ®rst 48 h following irradiation ( Figure 2a) ; in L3055 cells apoptosis increased steadily over a 4 day period ( Figure 2b ) and in MUTU BL cells only occurred at a low level during the ®rst 48 h, but increased between 48 and 96 h (Figure 2c ). In all parental lines, radiation-induced apoptosis had peaked by 96 h and then either reached a plateau at less than 100% (as in L3055, Figure 2b ) or started to decline (as in CHEP and MUTU, Figure 2a and c) due to regrowth of surviving cells.
The presence of Bcl-2 reduced the level of radiation-induced apoptosis in all three lines (Figure 2a ± c) , although in the case of MUTU/Bcl-2 the degree of protection in the ®rst 48 h was only minor in comparison with that observed in CHEP/Bcl-2 and L3055/Bcl-2. Signi®cantly, repression of apoptosis in the Bcl-2-expressing transfectant lines was not sustained. Thus, towards the end of the time course, while surviving parental cells were re-growing, the rate of apoptosis in Bcl-2-expressing counterparts increased, with CHEP/Bcl-2 cells exhibiting the highest degree of death. Indeed, by 7 days, the proportion of apoptotic cells was higher in the CHEP/Bcl-2 and MUTU/Bcl-2 transfectants than in the parental populations (Figure 2a and c) . This suggested that, although Bcl-2 protected against radiation-induced apoptosis in the short term, survival of BL cells was not sustained since re-growth of the rescued cells appeared to be inhibited.
Bcl-2 expression in BL cells has varied eects on longterm proliferative capacity
In order to determine whether the presence of Bcl-2 adversely aected the long-term proliferative capacity of BL cells, clonogenic outgrowth experiments were performed on CHEP and MUTU parental lines and on their Bcl-2-expressing counterparts using a limiting dilution technique. Figure 3 shows re-growth of cells following irradiation with 4 Gy and serial dilution in 96-well plates. The presence of Bcl-2 conferred a longterm survival disadvantage to CHEP BL cells, with Bcl-2 transfectants requiring a 16-fold increase in cell concentration, compared to parental cells, before regrowth occurred in any of the wells (Figure 3a) . The lower proliferative capacity of CHEP/Bcl-2 transfectants was maintained at higher cell concentrations. By contrast, the presence of Bcl-2 in MUTU BL cells conferred a long-term survival advantage over parental cells. Thus, following irradiation, Bcl-2 transfectants were able to re-grow at a concentration of 16-fold less than parental cells and this survival advantage was maintained at higher concentrations ( Figure 3b ). Therefore, depending on the cell context, Bcl-2 may in¯uence irradiated BL cell survival either positively or negatively. In order to determine the basis for the contrasting eects of Bcl-2 in irradiated BL cells, the cell cycle was monitored by¯ow cytometric analysis and also total cell numbers were assessed at daily intervals over a period of 1 week following irradiation. As shown in Figure 4a , in the CHEP/Bcl-2 line a decreased number of cells in S-phase and an increased number of cells in G2 were observed at 24 h, suggesting that both a G1 and G2 block had occurred. In the case of MUTU/Bcl-2, the majority of cells appeared arrested in the G2 phase of the cell cycle by 24 h ( Figure 4b ) and there was little evidence of a G1 block. By 96 h after irradiation, CHEP/Bcl-2 cells were mostly in the G1 phase (Figure 4a ), whereas MUTU/Bcl-2 cells were distributed throughout the cell cycle ( Figure 4b ). Neither CHEP/Bcl-2 nor MUTU/Bcl-2 cells increased in number after irradiation ( Figure 5 ), indicating that in both lines growth arrest had occurred, with CHEP/ Bcl-2 cells halting in G1 and MUTU/Bcl-2 cells arresting in all phases of the cell cycle.
We wondered whether the dierent responses of these BL lines were related to their p53 status. The p53 genotype of CHEP was wild type while MUTU contained a mutant allele with mutations at codons 234 and 245 (Tyr?Asn and Gly?Asp respectively). Therefore, CHEP cells may preferentially arrest in G1 under the in¯uence of wt p53 whereas the response of MUTU cells may be modulated by the presence of mutant p53. To determine whether Bcl-2 aected BL cell growth in a p53-dependent manner, we next compared, without irradiation, the long-term growth characteristics of CHEP (wt/wt p53) and MUTU (wt/ mu p53) with their Bcl-2-expressing counterparts. The rate of proliferation was monitored over a period of four weeks by assessing the time to reach con¯uency of cells serially diluted in 96 well plates ( Figure 6 ). CHEP/ Bcl-2 cells (wt/wt p53) took longer to reach con¯uency than CHEP parental cells. By contrast, the proliferation rate of MUTU/Bcl-2 cells (wt/mu p53) was marginally increased relative to the MUTU parental cells. Thus, the capacity of Bcl-2 to aect cell cycle in BL cells correlated with p53 status.
Cooperation between Bcl-2 and CD40 in irradiated BL cells
It seemed plausible that micro-environmental signals might cooperate with Bcl-2 to promote BL cell survival by aecting the cell cycle. Since ligation of CD40 on the surface of BL cells generates signals that prevent growth arrest in G1 (Wang et al., 1996) , we investigated the extent to which CD40 aected survival of irradiated Bcl-2-expressing BL cells. Figure 7 shows the apoptotic responses of CHEP/Bcl-2 and MUTU/Bcl-2 cells in the presence and absence of recombinant CD40-ligand (CD40L). Inclusion of CD40L at the time of irradiation reduced apoptosis in CHEP/Bcl-2 cells by approximately 50% at the end of the 7-day time course shown ( Figure  7a ) but, by contrast, caused an increase in apoptosis in MUTU/Bcl-2 cells over the same time period ( Figure  7b ). Cell-cycle analysis of viable cells at 24 h revealed a G2 block in CHEP/Bcl-2 and MUTU/Bcl-2 cells regardless of the presence of CD40L (Figure 8a and b) . However, by 96 h, CHEP/Bcl-2 cells had become arrested in G1 in the absence of CD40L. Ligand-treated cells, on the other hand, were not G1-arrested at this time ( Figure 8a ). Irradiated MUTU/Bcl-2 cells showed no evidence of a selective block in cycle and the inclusion of CD40L had no eect on cell cycle distribution ( Figure  8b ).
These results demonstrate that CD40 can co-operate with Bcl-2 to promote survival of irradiated BL cells, but only in cells that undergo G1-arrest. CD40 appeared to function by preventing such growth arrest. To obtain further support for this idea, we tested the eects of treatment of BL cells with CD40L at various times after irradiation. We reasoned that greater protection might be obtained by adding CD40L at a time when cells were about to initiate G1 arrest. Figure 9 shows apoptosis levels in irradiated CHEP/ Bcl-2 transfectants in the presence and absence of CD40L, added either at the time of irradiation or up to 96 h after irradiation. Repression of apoptosis by CD40L increased with time of delay of addition of the reagent, up to a maximum at 48 h, after which time its eectiveness declined. However CD40L added at 96 h after irradiation was still more eective than ligand added at the time of irradiation. Therefore, optimum repression of apoptosis by CD40L could be achieved by delaying addition of CD40L until shortly before G1 arrest was initiated.
Discussion
Apoptosis is a common cellular response to girradiation and cell survival following irradiation is enhanced by factors which, directly or indirectly, inhibit the apoptotic process. Here, we have analysed the apoptotic response of human B cells to girradiation focussing on the eects of expression of the prototype apoptosis-repressor molecule, Bcl-2, and the consequences of activation of the survival pathway triggered by CD40-ligation. Using Burkitt lymphoma cell lines, an established system for modelling human B-cell apoptosis in vitro Henderson et al., 1991; Milner et al., 1992 Milner et al., , 1993 , we have demonstrated: (1) that radiation-induced apoptosis can be inhibited by Bcl-2, (2) that, whilst Bcl-2 provides a potent short-term survival signal, a proportion of Bcl-2-rescued cells subsequently die in the absence of additional survival signals, (3) that the long-term proliferative capacity of BL cells following irradiation can be either increased or decreased by Bcl-2, depending on the BL line, (4) that these dierences correlate with both dierential eects of Bcl-2 on cell cycle and dierences in p53 status and (5) that CD40-ligation can inhibit apoptosis in G1-arrested Bcl-2-expressing cells by preventing growth arrest.
Following transfection of Bcl-2 into three dierent group 1 BL cell lines, all lines exhibited resistance to g-radiation-induced apoptosis. Bcl-2-expression has been shown previously to protect human B cells from other apoptotic stimuli, including growth/ survival factor withdrawal, antigen receptor crosslinking and Ca 2+ -ionophore treatment Holder et al., 1993; Milner et al., 1992 Milner et al., , 1993 Wang et al., 1996) . Bcl-2 has also been shown to repress apoptosis in response to DNA damage in a variety of systems (Collins et 1996; Sentman et al., 1991; Strasser et al., 1994; Soldatenkov et al., 1996) . Interestingly, we noted that the presence of Bcl-2 was not sucient to maintain prolonged resistance to apoptosis and all three Bcl-2 transfectants showed evidence of increased apoptosis by one week after irradiation, with one cell line (CHEP/Bcl-2) showing a markedly high level (up to 60%). When we investigated the long term proliferative capacity of these cells we found that expression of Bcl-2 had varied eects on BL cells: in one line (CHEP/Bcl-2), the proliferative capacity of the cells was decreased in comparison with parental cells, but by contrast, in another line (MUTU/Bcl-2) the rate of proliferation was increased. These results accord with those of previous studies that investigated clinical prognosis in a variety of tumours in which Bcl-2 was either expressed or absent. As bcl-2 is the prototype survival gene, it might be expected that clinical prognosis would be consistently poorer in tumours expressing Bcl-2 protein. However, in some cases prognosis is actually better when tumours express Bcl-2 than when they do not (Pezzella et al., 1992; Piris et al., 1994; Tjalma et al., 1997) . Our results suggest an explanation for this: although the presence of Bcl-2 provides short-term enhancement of survival after irradiation, it can also lead to delayed apoptosis. Similar observations, that Bcl-2 represses apoptosis initially but does not promote clonogenic survival, have been made recently by others in various tumour lines responding to DNA damage (Kyprianou et al., Lock and Stibinskiene, 1996; Walker et al., 1997) .
Our results also suggest an explanation for the dierent proliferative responses of dierent Bcl-2-expressing BL lines after irradiation. The dierential response of the two BL lines used in this study correlated with dierential eects of Bcl-2 on growth arrest. Thus, although both Bcl-2-expressing BL lines were found to undergo growth arrest after girradiation, arrest occurred in dierent phases of the cell cycle. In previous studies in which Bcl-2 has been shown to cause growth arrest, inhibition has generally been observed in progression from G1 to S-phase (Borner, 1996; Linette et al., 1996; Mazel et al., 1996; O'Reilly et al., 1996; Pietenpol et al., 1994) . Cell cycle analysis of the two BL lines investigated here showed that, while one (CHEP/Bcl-2) did arrest in G1, the other (MUTU/Bcl-2) arrested in all phases of the cell cycle. Therefore it is possible that these dierences are responsible for the dierences in long-term proliferative capacity. Thus, if a Bcl-2-induced G1 arrest is more dicult to overcome than growth arrest induced in all phases of the cell cycle, cells arrested in G1 would exhibit a long-term proliferative disadvantage. Indeed, previous studies have noted that Bcl-2-expressing cells arrested in G1 are refractory to cell cycle progression (Nunez et al., 1990; Marvel et al., 1994) . We have also found similar observations in Bcl-2-expressing BL cells which have undergone G1-arrest following withdrawal of serum (JM Levens and CD Gregory, unpublished observations). The mechanism by which Bcl-2 induces growth arrest in G1 requires further investigation, but other studies have suggested that failure of cdc2 induction, sustained levels of cyclin-dependent kinase inhibitor p27 and maintenance of dephosphorylated retinoblastoma protein (Linette et al., 1996; Marvel et al., 1994; Mazel et al., 1996) could be contributing factors.
Our results show that Bcl-2-induced growth arrest of BL cells following g-irradiation can occur in either early or late cycle. As the two BL lines dier in p53 status and as p53 is known to regulate growth arrest in G1 (Bates and Vousden, 1996) , we speculate that differences in Bcl-2-induced growth arrest could be due to dierences in p53. Thus, Bcl-2 may induce growth arrest in G1 by interacting with p53-mediated growth arrest pathways in cells homozygous for wt p53. If this were the case we reasoned that we would observe a dierential eect of Bcl-2 on the normal growth of BL cells diering in p53 status. In accordance with this, wt/ wt p53 CHEP/Bcl-2 cells grew more slowly than their parental counterparts over a period of four weeks, whereas wt/mu p53 MUTU/Bcl-2 cells grew slightly more rapidly than the parental line. Therefore, a dierential eect of Bcl-2 on cell growth in BL lines is apparent even in the absence of radiation with cells expressing only wt p53 showing a slower rate of growth.
Ligation of CD40, a member of the tumour necrosis factor receptor (TNFR) family of cell surface receptors whose natural ligand is expressed transiently on the surface of activated T cells, triggers multiple signalling pathways initiated by a family of proteins containing the TRAF (TNFR-associated factor) domain (see Tewari and Dixit, 1996) . Our previous results have shown that CD40-mediated rescue of B cells from apoptosis triggered by antigen receptor cross-linking is mediated by the prevention of G1 arrest and maintenance of hyperphosphorylation of the retinoblastoma protein (Wang et al., 1996) . We have demonstrated here that prevention of G1 arrest in CHEP/Bcl-2 cells following irradiation is also the mechanism by which CD40L can rescue from radiation-induced apoptosis. Indeed, optimum rescue by CD40L was achieved when CD40L was added 48 h after irradiation -the time at which G1 arrest was about to be initiated. The presence of CD40L did not reduce levels of apoptosis in Bcl-2 expressing BL cells that were growth arrested in all phases of the cell cycle. Therefore, for promotion of survival, CD40 signals primarily operate in G1. In the murine B-cell line, WEHI-231, G1 arrest following antigen-receptor crosslinking can be prevented by signals generated at CD40 that activate CDK4 and CDK6 (Ishida et al., 1995) . It will be of interest to determine whether cyclin/CDK complexes active in transition through G1 are also a requirement for rescue from radiationinduced apoptosis.
The present study provides a rationale in vitro for the lack of reproducible correlations between Bcl-2 expression and tumour prognosis in vivo. The survival of patients presenting tumours which express Bcl-2 protein may be better, unchanged, or worse than of those with similarly classi®ed tumours which lack Bcl-2 (Campos et al., 1993; Herod et al., 1996; Lepelley et al., 1995; Pezzella et al., 1992; Piris et al., 1994) and high Bcl-2 expression has been reported to be associated with low tumour cell proliferation (Silvestrini et al., 1996; Wilson et al., 1997) . Whilst a number of explanations may be oered to account for such observations, our results suggest that dierential eects of Bcl-2 on cell cycle arrest, the activity of wt p53 and the availability of additional, micro-environmental signals that promote cell survival or cell growth may critically determine ultimate tumour cell fate. We demonstrate here that the presence of Bcl-2 promotes short-term suppression of apoptosis in irradiated B-lymphoma cells, but can be detrimental to long-term cell survival, an observation which accords with the lack of association between patient survival time and Bcl-2-expression in their Bcell lymphomas (Pezzella et al., 1992; Piris et al., 1994) . The expression of Bcl-2 together with ligation of CD40 provides a highly eective combination which promotes long-term survival of irradiated cells, indicating that local availability of CD40L could be an important determinant of resistance of B-lymphoma cells to therapy.
Materials and methods

Cell lines
Cells were cultured at 378C in an atmosphere of 5% CO 2 in air in RPMI 1640 medium containing 10% FCS from batches pre-screened for their ability to support proliferation. The EBV-positive line MUTU has been described elsewhere (Gregory et al., 1990) . The EBV-negative line L3055 was established from an L3 category leukemia and carries a t(8;14) translocation. The group 1 cell surface phenotype CD10 + CD23 7 CD39 7 CD77 + was monitored using a panel of monoclonal antibodies (mAbs) (Gregory et al., 1990) . The group 1 phenotype was originally described for EBV-positive cells and is also characterised by restriction of EBV latent protein expression to EBNA-1 alone and absence or low expression of Bcl-2 Rowe et al., 1987) . The EBV-negative line L3055 is group 1-like in cell surface phenotype and also lacks expression of Bcl-2 . MUTU transfectants expressing high levels of Bcl-2 protein were obtained using the pCDj-bcl-2 plasmid (obtained from Y Tsujimoto) as described . Control transfectants were derived in parallel using the empty vector. Bcl-2-expressing L3055 and CHEP cells were obtained after transfection of the plasmid pEFbcl-2-MC1NeopA (provided by S Cory) as described (Wang et al., 1996) .
Immunoblotting
Bcl-2 protein expression was monitored by Western blotting using the Bcl-2-speci®c mouse mAb Bcl-2/124 as described . Protein was visualised using ECL reagents (Amersham International).
Cell cycle analysis
Cells were stained with propidium iodide (20 mg/ml) after ®xation in PBS containing 1.0% paraformaldehyde and 0.1% Triton X-100. DNA histograms were obtained using the FACScan (Becton-Dickinson), two-dimensional dot plots of forward versus 908 light scatter being used to analyse selectively those cells which were viable at the point of ®xation as described (Dive et al., 1992) . Vertical scales were adjusted to allow direct comparison of histograms.
Irradiation and measurement of apoptosis
Cells (3610 5 per ml in culture medium in polystyrene universal containers) were exposed to 0 to 4 Gy cobalt-60 g-rays from a Pantec irradiator at a dose rate of 0.05 Gy per s. Cells were subsequently cultured at a density of 3610 5 /ml in either 2 ml or 6 ml cultures in 24-well or 6-well plates (Nunc), respectively. Where indicated cultures contained 0.5 mg/ml soluble trimeric recombinant CD40-ligand (Wang et al., 1996) which was included in the medium prior to irradiation or which was added at the indicated times after irradiation. Quantitative assessment of apoptosis was carried out routinely by monitoring forward and 908 light scatter characteristics of unstained cells as described (Dive et al., 1992) using the FACScan. For each sample, 5000 cells were analysed. Diagnostic characteristics of apoptosis were assessed by¯uorescence microscopy of acridine orange-stained cells .
Clonogenic assays
Irradiated (4 Gy) cells were serially diluted in roundbottomed 96-well plates from 10 4 cells per well down to four cells per well. Plates were assessed microscopically and wells scored as regrowing when cells covered the base of the wells. The medium was replenished once a week. Three separate experiments were performed, two with wells in quadruplicate and one with wells in duplicate. The scores from all the wells were collated and the number of wells regrowing expressed as a fraction of one (a score of one indicates that all 10 wells regrew).
Analysis of cell proliferation rate
Cells were serially diluted in round-bottomed 96-well plates in triplicate from 10 4 cells per well down to four cells per well. Plates were assessed microscopically at daily intervals and the number of days taken to reach con¯uency noted. The medium was replenished once a week.
